tion and atrial flutter overlap, for the purposes of are unlikely to resolve until the underlying disease process has improved. Urgent cardioversion is indicated for hemodythis discussion they will be considered as one entity those patients who remain in AF. Diltiazem is the preferred agent for rate control, while procainamide and amiodarone are generally considered to be the antiarrhythmic agents of choice.
Pathophysiology
Atrial fibrillation is a rhythm in which atrial activation is disorganized and the atria do not contract effectively. It is probably caused by a variant of reentry in which one or more activation wavefronts travel in endlessly varying paths, giving rise to subsidiary wavelets [2] [3] [4] . Atrial enlargement helps sustain AF by accommodating more wavelets [5] .
AF is particularly common in ICU patients with cardiovascular disorders, respiratory failure, and sepsis [1, 6] . The etiology is largely multifactorial, with hypoxia, electrolyte disturbances (hypokalemia, hypomagnesemia), myocardial ischemia, anemia, increased sympathetic tone, ''cardiotonic drugs,'' and atrial distention being implicated [1] . Pulmonary hypertension with right atrial distention may be an important precipitant in patients with respiratory failure and sepsis [6] . Underlying cardiovascular disease, diabetes, and advanced age increase the risk of developing atrial arrhythmias [1] . Drugs such as catecholamines and theophylline increase the risk of developing atrial tachyarrhythmias and increase the ventricular response, making rate control more difficult [7] [8] [9] [10] . Patients with sudden onset of AF and no obvious underlying cause should be investigated for the possibility of pulmo-in whom spontaneous conversion will occur in up studies of the treatment of AF in ICU patients. The treatment algorithm outlined in this article is based to 67% of patients [11] . The development of AF in critically ill patients is frequently associated with on the synthesis of data from the above cited studies [12, [14] [15] [16] , as well as those randomized controlled increased pulmonary capillary wedge pressure, decreased cardiac output, pulmonary hypertension, studies that have enrolled patients presenting to the hospital with new onset AF [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . AF is a common and worsening respiratory failure. In addition, AF increases morbidity and mortality in critically ill pacomplication in postoperative coronary artery bypass patients; this is a distinct clinical problem tients as a result of systemic emboli.
In critically ill patients, the development of AF which will not be reviewed in this article. decreased the mean energy required for successful transthoracic cardioversion. The role of this apThe aim of electrical therapy is to provide a current through the myocardium to change enough proach in ICU patients remains to be determined. In the ICU setting it is highly likely that AF will myocardial cells to the same electrical state for a sufficient time to break the reentrant circuits or recur soon after successful cardioversion, as the precipitating conditions still exist. Consequently produce electrical homogeneity. This allows a stable rhythm to be reestablished from the sinus node.
antiarrhythmic drugs, such as procainamide or amiodarone, administered before or soon after the Animal experiments have shown that the period of homogeneity needs to be 4-12 msec. More orgacardioversion may be useful for prevention of recurrence. Due to the risk of torsades de pointe, all nized arrhythmias such as AF require less energy to break the circuit (5-10 J internal, 20-100 J external) antiarrhythmics should be avoided for at least 4-6 hours in patients who have received ibutilide. compared to disorganized rhythms (e.g., ventricular fibrillation, 10-13 J internal, 200-300 J external).
Rate Control. Rate control can improve hemodyThe current delivered to the heart is determined by both the energy chosen (J) and the transthoracic namics even if the patient remains in AF. Digoxin is commonly used in the treatment of AF in ICU impedance [31, 32] . The use of bare paddles without a couplant (gel/cream) results in very high trans-
patients. Yet in the critically ill ICU patient, digoxin is probably the most ineffective drug in controlling thoracic impedance [31, 32] . Impedance may be reduced by strong pressure on the paddles, anterothe ventricular response in AF. Digoxin decreases ventricular response in AF by vagotonic mechaposterior positioning of the paddles, repetitive shocks, and delivery of the shock during expiration nisms [35, 36] . In critically ill patients, AF occurs in the setting of high sympathetic tone and frequently [31, 32] . Various types of electrodes may be used for cardioversion, including the traditional handheld with the use of vasopressors and inotropic agents, a situation in which digoxin is likely to be ineffective. electrode paddles and self-adhesive monitor-defibrillator pads. The paddles/pads should be placed Digoxin has been demonstrated to have limited value in the management of patients presenting to in a position that will maximize current flow through the myocardium. The most commonly emhospital with acute AF and in AF after coronary artery bypass graft surgery. Schreck et al.
[37] comployed placement is apex-anterior. The anterior electrode should be placed on the right of the upper pared the effects of intravenous diltiazem with digoxin for ventricular rate control in the emergent sternum below the clavicle; the apex electrode should be placed to the left of the nipple, with the treatment of acute atrial fibrillation and flutter. By 60 minutes, the mean ventricular response had decenter of the electrode in the midaxillary line [33] . In women, placement of paddles on the breast creased from 150 to 99 beats/min in the diltiazem group and 144-129 beats/min in the digoxin group should be avoided, since in this position transthoracic impedance is high. Placement of the apex (p ‫ס‬ 0.01, for differences between groups). Tisdale et al. [38] demonstrated that ventricular rate control electrode adjacent to or under the breast is preferable [31] .
occurs more rapidly with intravenous diltiazem than digoxin in AF after coronary artery bypass graft Synchronization of shocks is extremely important. Properly synchronized shocks rarely, if surgery. Other studies have similarly demonstrated poor rate control in patients treated with digoxin ever, induce ventricular fibrillation; failure to synchronize shocks on the R wave may lead to inadver-[27, 39, 40] . Furthermore, it is important to emphasize that digoxin does not increase the rate of content delivery of a shock in the vulnerable period and is likely to produce ventricular fibrillation [33] .
version to sinus rhythm. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group randomized 239 Because some defibrillators default to an unsynchronized mode after each shock, the operator patients (non-ICU) with new onset atrial fibrillation to receive digoxin or placebo [27] . At 16 hours, 46% must remember to reenable the synchronizer before each subsequent shock. Shocks to convert atrial of the placebo group and 51% of the digoxin group had converted to sinus rhythm (not significant). As fibrillation should begin at energy levels of 100 J, with the energy for subsequent shocks increased digoxin provides poor rate control and has a very narrow therapeutic index, we believe that this drug in increments of 50-100 J. Atrial flutter is an easier rhythm to convert and shocks should begin at 50 should be avoided except in ICU patients with poor left ventricular function [40] . J [33] .
For those patients who fail cardioversion, pace Diltiazem appears to be an effective alternative to digoxin for rate control. Ellenbogen et al. [41] termination of AF may be effective. Recently Oral reported that 79 of 84 patients (94%) with acute AF patients has never been tested in a randomized controlled study. These agents might best be used responded to a bolus dose of 20 or 25 mg diltiazem with a greater than 20% reduction in heart rate from in patients with persistent atrial fibrillation in preparation for direct-current cardioversion. The choice baseline, conversion to sinus rhythm, or a heart rate less than 100 beats/min. Hypotension was the most between amiodarone and procainamide is determined largely by the drugs side-effect profile and common side effect, occurring in 13% of patients. In an additional report, these authors demonstrated cost, with amiodarone being recommended in patients with severe left ventricular dysfunction. that a 10 to 15 mg/hr continuous infusion of intravenous diltiazem was effective in maintaining rate Clemo et al.
[16] described 38 critically ill patients with AF who were resistant to conventional heart control [42] . Additional studies have demonstrated a response rate of 93 and 97% [43] [44] [45] . Coadminisrate control measures and who were treated with amiodarone. An infusion of amiodarone (over 1 tration of calcium is effective in limiting hypotension in diltiazem-treated patients.
hour) was associated with a significant decrease in heart rate of 37 ‫ע‬ 8 beats/min and a significant Esmolol, an ultrashort-acting, nonselective ␤-blocker has also been demonstrated to be effective increase in systolic blood pressure of 24 ‫ע‬ 6 mmHg. In the 22 patients with indwelling pulmoin controlling the ventricular response in AF [46] [47] [48] . Metoprolol (intravenously or orally) is an alternanary artery catheters, the cardiac index increased over the first 2 hours from 2.4 ‫ע‬ 0.3 L/min/m 2 to tive agent. ␤-blockers are particularly effective in patients with increased sympathetic tone. These 2.8 ‫ע‬ 0.3 L/min/m 2 (p < 0.05). In the first 24 hours of the infusion 18 patients (48%) converted to sinus agents may cause hypotension, particularly in unstable ICU patients. Magnesium has been shown to rhythm. Kumar [12] studied the efficacy of intravenous amiodarone in eight patients with severely reduce the ventricular response in AF, with a greater effect when combined with digoxin [49, 50] . Magnecompromised left ventricular function who developed AF in the ICU. Intravenous amiodarone was sium may act by increasing the atrio-His interval and atrioventricular nodal refractoriness [51, 52] .
effective in seven of the eight patients. Six of the seven patients reverted to sinus rhythm within 30 Adenosine has virtually no role in the acute treatment of AF, given its very short half-life [33] . The minutes, with the cardiac index, pulmonary capillary wedge pressure and mean arterial pressure reagents used for rate control are listed in Table 2. maining stable during the infusion. Oral and intravenous amiodarone increase atrioPharmacologic Cardioversion. A number of antiarrhythmic drugs including procainamide, amioventricular nodal refractoriness and intranodal conduction [53] [54] [55] . These changes are thought to be darone, flecainide, propafenone, sotalol, and ibutilide have been studied in patients with acute mediated by the drug's calcium channel blocking action and its noncompetitive antiadrenergic effect. atrial fibrillation in a non-ICU setting [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . These trials are listed in Table 3 (inadequately powered, Intravenous amiodarone has a minimal effect on the effective refractory periods of atrial, ventricular, uncontrolled studies after cardiac surgery were excluded from this analysis). The length of observaand His-Purkinje tissues, and it does not prolong the H-V interval, the QRS interval, or the QTc duration in many of these studies was short (i.e., 2.5 hours). Only two studies have prospectively investition. One hypothesis for this difference is that many of amiodarone's electrophysiologic effects require gated the management of AF in ICU patients (Table  1) . Procainamide and amiodarone are generally long-term administration, which allows greater penetration of the drug and its active metabolite considered to be the antiarrhythmic agents of choice in acutely ill ICU patients [12, 14, 16] . Howinto these tissues [56] . The typical adverse effects seen with chronic use of oral amiodarone (dermatoever, the efficacy of these agents in critically ill ICU logic, ophthalmologic, central nervous system, longed by both renal and hepatic disease. A close relationship has been found between the plasma thyroid) are not observed with intravenous amiodarone [57,58]. Hypotension and bradycardia, the concentration and the therapeutic effects of procainamide, with a suggested therapeutic range varying most common adverse events reported with intravenous amiodarone, usually occur during the loadfrom 4 to 8 g/ml [69] . QT prolongation and polymorphic ventricular tachycardias (torsades de ing infusion [57] . However, acute hepatotoxicity with liver function test abnormalities has been repointes) may occur with this drug, necessitating close monitoring of both drug levels and the QTc ported in 9-17% of patients [57, 59] . Hepatic dysfunction appears to be short lived and reversible.
interval on a 12-lead electrocardiogram. Ibutilide fumarate is a new class III intravenous The early acute hepatitis reported with parenteral amiodarone may be a toxic effect of the carrier antiarrhythmic agent indicated for the acute termination of atrial fibrillation and flutter [71, 72] . It has vehicle polysorbate 80 [60, 61] . Amiodarone has been associated with acute pulmonary toxicity presa short half-life due to extensive tissue distribution and is available only for administration as an intraenting as acute respiratory distress syndrome (ARDS). This syndrome has been reported after thovenous bolus (1 mg dose) [73] . The drug has minimal hemodynamic effects, even in patients with racic surgery and in infants [62] [63] [64] [65] . Donaldson et al. [66] described three patients with ARDS who depressed ventricular function [74] . Ibutilide prolongs repolarization in the atria and ventricle by were treated with amiodarone and had histologic changes of widespread lipoid pneumonia at auenhancing the inward depolarizing, slow sodium current and by blocking Ik r [71] [72] [73] . Ibutilide causes topsy. These authors suggest that high oxygen concentrations may be a risk factor for acute a dose-dependent prolongation of the QT interval, which is maximal at the end of the infusion and amiodarone pulmonary toxicity, while preexisting pathology such as ARDS may mask its developreturns to baseline within 2-4 hours following infusion [71] [72] [73] . Torsade de pointes is the most cliniment. Amiodarone should therefore be used with caution in this group of patients. It is important to cally important adverse effect, being reported in 4.3% of patients [75] . The role of ibutilide in critically note that amiodarone has been shown to significantly increase plasma concentrations of digoxin by ill patients remains to be determined. This drug may have a role in enhancing termination of AF 60-70% within 24 hours of coadministration [67, 68] . This interaction is clinically significant and result in in patients undergoing electrical cardioversion or atrial overdrive pacing [34, 76] . signs and symptoms of digitalis toxicity.
Procainamide is one of the oldest antiarrhythmic Based on the above information we suggest the following approach to the critically ill patient with drugs, having been used in 1936 (where it was applied topically to the heart during surgery) [69] .
AF. Hemodynamically unstable patients should be electrically cardioverted followed by an infusion of Procainamide is a class IA antiarrhythmic drug with wide antiarrhythmic indications. Intravenously the procainamide or amiodarone (as outlined above). A loading dose of procainamide, amiodarone, or drug has negative inotropic and hypotensive effects [70] . Nearly half of the administered dose is elimiibutilide followed by repeated attempts at directcurrent cardioversion should be considered after nated unchanged in the urine, with 10-23% of the drug being acetylated to produce N-acetylprocainethree failed attempts at cardioversion. In ''hemodynamically stable'' patients with AF, all correctable amide (NAPA). The elimination of the drug is pro-factors such as hypokalemia (K < 4 mmol/L), ane-15 mg is administered, followed by an infusion of up to 15 mg/hr). Procainamide or amiodarone mia, and hypoxemia should be corrected. Magnesium supplementation (2 g magnesium sulfate in should be considered in patients who remain in AF. Amiodarone should be avoided in patients re-10 ml dextrose in water over 5 minutes) should be considered except in hypermagnesemic patients ceiving high inspired oxygen concentrations. In patients who remain in AF after 12-24 hours we (serum magnesium > 2.5 mg/dl). Drugs such as aminophylline and dopamine should be stopped.
suggest direct-current electrical cardioversion. This algorithm is outlined in Figure 1 . The dosages of Pain and anxiety, which increases sympathetic activity, should be treated. We then suggest rate conthe agents used for cardioversion of AF are listed in Table 4 . There are no data on the optimal duratrol with diltiazem (5 mg boluses every 5 minutes until rate control is achieved or a maximal dose of tion of antiarrhythmic therapy. However, as AF is likely to recur if the drug is terminated prematurely, because of their negative inotropic effect and concerns regarding the use of calcium channel blockers we suggest continuation of the drug (intravenously or orally) until the precipitating factors have either in acute AMI, these agents are not recommended as first-line agents. The roles of class I and class III improved or resolved.
antiarrhythmic agents and electric shock for converting persistent AF are unclear as is the role of Atrial Fibrillation and Acute Myocardial antiarrhythmic agents for the prevention of further episodes of AF in patients who convert to sinus Infarction rhythm. Anticoagulation with heparin is indicated in patients who remain in AF for more than 24 Atrial fibrillation associated with acute myocardial hours or have recurrent episodes of AF. infarction (AMI) most often occurs within the first 24 hours and is usually transient but may recur. The incidence of AF in AMI ranges from 9 to 16% [77] [78] [79] [80] [81] .
Anticoagulation
Its etiology includes left ventricular dysfunction, pericarditis, metabolic abnormalities, excess cateAccording to the most recent guidelines on anticholamine release or iatrogenic factors (e.g., use of thrombotic therapy from the American College of sympathomimetic drugs) [77, [80] [81] [82] . The appearChest Physicians, anticoagulation is not required ance of atrial fibrillation, however, is often a manifor AF of less than 48 hours [83] . This recommendafestation of extensive left ventricular systolic tion is supported by the study of Weigner et al.
[11] dysfunction [77, 78, 82] . Data from the GUSTO-1 who demonstrated 3 thromboembolic events in 357 study suggest that patients who develop AF frepatients (1%) with new onset AF (<48 hours) who quently have extensive coronary artery disease with converted to sinus rhythm. On the other hand, full poor reperfusion of the infarct-related artery [77] .
anticoagulation is required in patients in whom AF Patients who develop AF in the setting of AMI are at has been present for more than 48 hours or its an increased risk of ischemic strokes [77, 78] . Atrial duration is uncertain. In patients planned for pharfibrillation in the setting of AMI independently premacologic cardioversion in whom AF has been dicts 30-day and 1-year mortality rates [77, 78] . present for more than 48 hours and who have not If AF causes hemodynamic compromise or ongobeen on chronic anticoagulation, transesophageal ing ischemia, direct-current cardioversion should echocardiography should be performed to exclude be performed. In the absence of congestive heart the presence of an atrial thrombus [84] . failure, bronchospastic disease, or atrioventricular block the most effective means of slowing the ventricular rate in AF is the use of intravenous ␤-adre-
Conclusion
noceptor blocking agents such as atenolol, esmolol, or metoprolol. Rapid digitalization will control the ventricular rate and improve left ventricular funcAtrial fibrillation is a common and clinically important arrhythmia in critically ill patients. As this tion. This method provides a slower response than intravenous ␤-adrenoceptor blocking agents. Acute arrhythmia is likely to persist until the underlying medical disorder has resolved, medical managedigitalization, however, may cause coronary and splanchnic vasoconstriction. Rate slowing may also ment is almost always required. 
